CUBT logo for press releases.jpg
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
March 31, 2024 19:00 ET | Curative Biotechnology, Inc. 
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company...
180_CC_horizontal_logo.png
180 Degree Capital Corp. Notes Support of Its Board Nominee, Matthew F. Mclaughlin, by Board of Directors of comScore, Inc.
March 26, 2024 09:00 ET | 180 Degree Capital Corp.
MONTCLAIR, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ: TURN) (“180 Degree Capital”) today noted the announcement by comScore, Inc. (“SCOR”) that SCOR’s Nominating...
Sidetrade renforce s
Sidetrade renforce son agilité avec la nomination d'une Cheffe de cabinet
March 07, 2024 05:47 ET | Sidetrade
Sidetrade, plateforme d’intelligence artificielle (IA) dédiée à la sécurisation et à la génération du cashflow des entreprises, annonce la nomination de Carole Benichou en tant que Cheffe de cabinet,...
SIDETRADE_LOGO_2019_MASTER_WEB.JPG
Sidetrade strengthens scalability with Chief of Staff appointment
March 07, 2024 05:47 ET | Sidetrade
Sidetrade, the global leader in AI-powered Order-to-Cash applications, announces the appointment of Carole Benichou as its new Chief of Staff and latest addition to the executive committee. This...
180_CC_horizontal_logo.png
180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for Second Month of Initial Measurement Period of its Discount Management Program
March 01, 2024 09:00 ET | 180 Degree Capital Corp.
MONTCLAIR, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (“180 Degree Capital”) (NASDAQ: TURN), noted today that the average discount between its estimated daily net asset value...
Osisko nomme David S
Osisko nomme David Smith à son conseil d'administration
January 24, 2024 08:00 ET | Redevances Aurifères Osisko Ltée
MONTRÉAL, 24 janv. 2024 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (« Osisko » ou la « Société ») (TSX et NYSE : OR) a le plaisir d'annoncer la nomination de M. David Smith à son...
20180109-ogr_200.jpg
Osisko Appoints David Smith to Its Board of Directors
January 24, 2024 08:00 ET | Osisko Gold Royalties Ltd.
MONTRÉAL, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (OR: TSX & NYSE) is pleased to announce the appointment of Mr. David Smith to its Board...
logo TRANSGENE.jpg
Transgene annonce la nomination de James Wentworth comme Directeur du Business Development
January 22, 2024 11:45 ET | Transgene S.A.
Strasbourg, France – Le 22 janvier 2023, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies contre le cancer reposant sur des vecteurs...
logo_TRANSGENE.jpg
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer
January 22, 2024 11:45 ET | Transgene S.A.
Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased...
Image1.png
Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer
January 04, 2024 10:25 ET | EVEXTA BIO
Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer Paul Gineste brings 25 years of experience in clinical development and strategy with leading international...